Cargando…
Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
BACKGROUND: Nanofiltration entails the filtering of protein solutions through membranes with pores of nanometric sizes that have the capability to effectively retain a wide range of viruses. STUDY DESIGN AND METHODS: Data were collected from 754 virus validation studies (individual data points) by P...
Autores principales: | Roth, Nathan J., Dichtelmüller, Herbert O., Fabbrizzi, Fabrizio, Flechsig, Eckhard, Gröner, Albrecht, Gustafson, Mary, Jorquera, Juan I., Kreil, Thomas R., Misztela, Dominika, Moretti, Elisa, Moscardini, Mila, Poelsler, Gerhard, More, John, Roberts, Peter, Wieser, Andreas, Gajardo, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754444/ https://www.ncbi.nlm.nih.gov/pubmed/32815181 http://dx.doi.org/10.1111/trf.16022 |
Ejemplares similares
-
Effective inactivation of a wide range of viruses by pasteurization
por: Gröner, Albrecht, et al.
Publicado: (2017) -
Prolonged (post‐thaw) shelf life of −80°C frozen AB apheresis plasma
por: Rijnhout, Tim W.H., et al.
Publicado: (2020) -
Frozen and freeze‐dried solvent/detergent treated plasma: Two different pharmaceutical formulations with comparable quality
por: Heger, Andrea, et al.
Publicado: (2022) -
Characterization and first‐in‐human clinical dose‐escalation safety evaluation of a next‐gen human freeze‐dried plasma
por: Cancelas, Jose A., et al.
Publicado: (2021) -
Surrogate test performance for SARS‐CoV‐2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?
por: Wendel, Silvano, et al.
Publicado: (2021)